查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球弹性体输液帮浦市场按类型、应用、终端用户产业及地区划分－预测至2030年
市场调查报告书
商品编码
1881226

全球弹性体输液帮浦市场按类型、应用、终端用户产业及地区划分－预测至2030年

Elastomeric Infusion Pumps Market by Type (Continuous Rate and Variable Rate), Application (Chemotherapy, Pain Management, Antibiotics), End-use Industry (Hospitals, Ambulatory Surgical Centers, Home-care Settings), and Region - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 242 Pages | 订单完成后即时交付

价格

全球弹性体输液帮浦市场预计将从 2025 年的 11.5 亿美元成长到 2030 年的 14.9 亿美元，预测期内复合年增长率为 5.3%。

调查范围
调查期 2023-2030
基准年 2024
预测期 2025-2030
单元 100万美元
部分 类型、用途、最终用户产业、地区
目标区域 北美洲、亚太地区、欧洲、中东和非洲、南美洲

随着医疗专业人员和患者越来越依赖携带式非电子设备进行精准、持续的药物输注，弹性体输液帮浦市场预计将稳定成长。在以患者为中心、可移动且简化的输註解决方案需求的推动下，肿瘤科、疼痛管理、麻醉科和居家医疗等领域的需求不断增长，也促进了市场发展。这些设备无需电池或复杂的电路即可实现可靠、精准的药物输注，从而提高患者的活动能力和依从性。

弹性体输液帮浦市场-IMG1

欧洲药品管理局 (EMA)、美国食品药物管理局(FDA) 等监管机构以及多个地区的卫生部门正在推出更严格的安全性、品质和生物相容性要求，迫使製造商开发新型多腔设计、流量控制系统和性能更优的弹性体。为减少医疗废弃物，目前的研究进展包括即时剂量监测、与智慧监测系统整合以及使用可回收和环保材料。

“到2024年，疼痛管理将占据弹性体输液泵市场最大的份额。”

由于弹性体输液帮浦在外科手术和慢性疼痛治疗​​的广泛应用，预计到2024年，疼痛管理将成为弹性体输液帮浦市场最大的份额。这些输液帮浦能够持续、精准地输送氢可酮和Fentanyl等止痛药，进而有效缓解疼痛并缩短住院时间。其便携性、易用性以及无需任何技术组件即可稳定输送药物的特性，使其成为住院和居家照护环境的理想选择。外科手术数量的增加，以及对患者舒适度和活动能力的日益重视，正在推动这些输液泵在疼痛治疗领域的应用。

“到2024年，医院在弹性输液泵市场中占据最大份额。”

预计到2024年，医院将成为弹性体输液帮浦市场最大的细分领域，这主要得益于各种治疗中对可靠、持续给药系统的巨大需求。这些输液帮浦广泛用于术后镇痛、化疗和抗生素给药，无需依赖电子元件或外部电源即可实现持续输注。其一次性无菌设计符合医院的感染控制要求，并降低了交叉感染的风险和设备维护需求。此外，手术量的增加、对加速病患復健的重视以及病患对低成本输液方案的偏好，都在推动医院对弹性体输液帮浦的采用。由于其操作简便、安全可靠且精准，弹性体输液帮浦已成为现代医院患者照护的重要工具。

“2024年，北美在弹性体输液泵区域市场占据主导地位。”

2024年，弹性体输液帮浦市场主要集中在北美，这主要得益于先进的医疗保健体系、尖端医疗设备的广泛应用以及癌症、心血管疾病和糖尿病等慢性病盛行率的上升。该地区的大部分优势归功于强有力的报销和支持政策，以及日益普及的门诊和居家医疗服务模式，所有这些因素都极大地推动了携带式、易于操作的输液系统的发展。市场领导者保持着强劲的整体地位，有利因素依然稳固，为进一步巩固市场领导地位创造了机会。此外，医院和专科诊所继续使用弹性体输液帮浦进行持续、耐受性良好的高剂量药物输注，用于疼痛管理和术后护理，从而提高患者舒适度并降低成本。

本报告分析了全球弹性体输液帮浦市场，提供了关键驱动因素和限制因素、竞争格局和未来趋势的资讯。

目录

第一章 引言

第二章执行摘要

第三章 主要发现

  • 弹性体输液帮浦市场的巨大机会
  • 北美弹性体输液帮浦市场按类型和国家划分
  • 按类型分類的弹性体输液帮浦市场
  • 按应用分類的弹性体输液帮浦市场
  • 按最终用途行业分類的弹性体输液泵市场
  • 按国家/地区分類的弹性体输液帮浦市场

第四章 市场概览

  • 介绍
  • 市场动态
    • 司机
    • 抑制因素
    • 机会
    • 任务
  • 未满足的需求和閒置频段
    • 弹性体输液帮浦市场未满足的需求
    • 閒置频段机会
  • 相互关联的市场与跨产业机会
    • 互联市场
    • 跨职能机会
  • 一级/二级/三级公司的策略性倡议

第五章 产业趋势

  • 波特五力分析
  • 宏观经济分析
    • 介绍
    • GDP趋势与预测
  • 价值链分析
  • 生态系分析
  • 定价分析
    • 按类型分類的弹性体输液帮浦平均销售价格
    • 平均售价分析：按地区划分
  • 贸易分析
    • 出口方案（HS编码901890）
    • 进口方案（HS编码901890）
  • 重大会议和活动（2025-2026）
  • 影响客户业务的趋势/颠覆性因素
  • 投资和资金筹措方案
  • 案例研究分析
  • 2025年美国关税的影响：弹性体输液帮浦市场
    • 介绍
    • 主要关税税率
    • 价格影响分析
    • 对国家的影响
    • 对终端用户产业的影响

第六章：科技、专利、数位化和人工智慧应用带来的策略颠覆

  • 主要新技术
    • 精密流量控制系统与多速率设计
    • 用于提高药物稳定性的尖端材料
    • 用于压力产生的弹性体膜
  • 互补技术
  • 邻近技术
  • 技术/产品蓝图
    • 短期（2025-2027 年）| 基础建设与早期商业化
    • 中期（2027-2030 年）| 扩张与整合
    • 长期（2030-2035 年及以后）| 成熟度与自主系统
  • 专利分析
    • 介绍
    • 调查方法
    • 弹性体输液帮浦市场专利分析（2015-2024）
  • 未来应用
    • 用于远端监测的数位健康整合
    • 拓展至兽医门诊护理
    • 提供生物製药和基因疗法等先进治疗方案
    • 生物发光指示膜
  • 人工智慧/生成式人工智慧对弹性体输液帮浦市场的影响
    • 主要应用案例和市场潜力
    • 弹性体输液帮浦加工的最佳实践
    • 人工智慧在弹性体输液帮浦市场的应用案例研究
    • 相互关联的相邻生态系及其对市场参与者的影响
    • 弹性体输液帮浦市场中客户对生成式人工智慧应用的准备情况
  • 成功案例和实际应用
    • 密西根大学部署 DOSI-FUSER 弹性体输注系统用于居家化疗
    • 儿童居家化疗（INTACT@HOME，加拿大）
    • 安宁疗护和临终症状管理（加拿大安大略省南部）

第七章永续性与监管环境

  • 地方法规和合规性
    • 监管机构、政府机构和其他组织
    • 业界标准
  • 对永续性的承诺
  • 永续性影响和监管政策倡议
  • 认证、标籤和环境标准

第八章：顾客状况与购买行为

  • 决策流程
  • 买方相关利益者和采购评估标准
    • 采购过程中的关键相关利益者
    • 采购标准
  • 招募障碍和内部挑战
  • 各个终端用户产业尚未满足的需求
  • 市场盈利
    • 潜在收入
    • 成本动态
    • 利润机会：按申请

9. 按类型分類的弹性体输液帮浦市场

  • 介绍
  • 连续速率
  • 浮动利率

第十章 按应用分類的弹性体输液帮浦市场

  • 介绍
  • 化疗
  • 疼痛管理
  • 抗生素
  • 其他用途

11. 依终端用户产业分類的弹性体输液帮浦市场

  • 介绍
  • 医院
  • 门诊手术中心（ASC）
  • 居家照护环境
  • 其他终端用户产业

12. 弹性体输液帮浦市场（依地区划分）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 亚太其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

第十三章 竞争格局

  • 概述
  • 主要参与企业的策略
  • 市占率分析
  • 收入分析
  • 公司估值和财务指标
  • 产品/品牌对比
  • 企业评估矩阵：主要企业（2024）
  • 公司评估矩阵：Start-Ups/中小企业（2024 年）
  • 竞争场景

第十四章：公司简介

  • 主要企业
    • BAXTER
    • B. BRAUN SE
    • NIPRO
    • AVNS
    • VYGON
    • WOOYOUNG MEDICAL CO., LTD.
    • SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.
    • AMBU A/S
    • PALEX
    • DAIKEN MEDICAL CO., LTD.
  • 其他公司
    • PROMECON GMBH
    • S&S MED
    • EPIC MEDICAL
    • MULTIMEDICAL SRL
    • TECNOLINE SPA
    • ZHEJIANG FERT MEDICAL DEVICE CO., LTD.
    • ACE MEDICAL
    • GAMASTECH SRL
    • FIRST MEDICAL SOURCE
    • DELTAMED
    • VIKYMED ITALIA SRL
    • CHANGZHOU MEDICAL BIOENGINEERING CO., LTD.
    • MAIS INDIA
    • NARANG MEDICAL LIMITED
    • ZEBRA MEDICAL

第十五章调查方法

第十六章：邻近及相关市场

  • 介绍
  • 限制

第十七章附录

Product Code: CH 9585

The elastomeric infusion pumps market is expected to reach USD 1.49 billion by 2030 from USD 1.15 billion in 2025, at a CAGR of 5.3% during the forecast period.

Scope of the Report
Years Considered for the Study2023-2030
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD Million)
SegmentsType, Application, End-use Industry, and Region
Regions coveredNorth America, Asia Pacific, Europe, the Middle East & Africa, and South America

The elastomeric infusion pumps market is projected for steady growth as healthcare providers and patients increasingly utilize portable, non-electronic devices for accurate, continuous drug administration. The increasing demand in oncology, pain management, anesthesia, and home care contributes to market growth, driven by the need for patient-centric, ambulatory, and simplified infusion solutions. These devices provide reliable and accurate medicine delivery without requiring batteries or complex circuitry, thereby improving patient mobility and compliance.

Elastomeric Infusion Pumps Market - IMG1

Regulatory entities, such as the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA), as well as several regional health organizations, have implemented more stringent requirements for safety, quality, and biocompatibility. This is pushing manufacturers to develop new multi-chamber designs, flow control systems, and better elastomers. To mitigate medical waste, current advancements encompass real-time dosage monitoring, integration with intelligent monitoring systems, and the utilization of recyclable, eco-friendly materials.

"Pain Management accounted for the largest share in the elastomeric infusion pumps market in 2024."

Pain management accounted for the largest share of the elastomeric infusion pumps market in 2024, driven by their widespread use in surgical and chronic pain treatments. These pumps provide a continuous, controlled dosage of analgesics like morphine or fentanyl, ensuring efficient reduction of pain while reducing hospital stays. Their portability, user-friendliness, and capacity to deliver consistent drug infusion without technological components render them optimal for both inpatient and home-care environments. The rise in surgical procedures, along with an increased focus on patient comfort and mobility, enhances their use in pain treatment applications.

"Hospitals accounted for the largest share of the elastomeric infusion pumps market in 2024."

In 2024, hospitals represented the largest segment of the elastomeric infusion pumps market, driven by a significant need for reliable and continuous drug delivery systems across various therapies. These pumps are extensively used for postoperative analgesia, chemotherapy, and antibiotic delivery, providing continuous infusion that is independent of electronic components or external power sources. Their disposable and sterile design complies with hospital infection control requirements, thereby reducing the risk of cross-contamination and the need for device maintenance. Additionally, the increasing number of surgeries, the focus on expediting patient recovery, and patients' preference for less-expensive infusion solutions have all contributed to their growing prevalence in hospitals. Elastomeric pumps are important tools for modern hospital-based patient care as they are easy to use, safe, and accurate.

"North America dominated the regional market for elastomeric infusion pumps in 2024."

In 2024, the elastomeric infusion pumps market was primarily concentrated in North America due to an advanced healthcare system, widespread adoption of cutting-edge medical devices, and a heightened incidence of chronic conditions, such as cancer, cardiovascular disease, and diabetes. Many of the benefits in this region stem from strong reimbursement policies, enabling policies, and increasing outpatient and home care service patterns, all of which heavily promote the development of portable and simple-to-use infusion systems. The continued existence of market leaders in a good overall position, with ample development of conducive factors, created further opportunities for market leadership development. In addition, hospitals and specialist clinics continuously utilize elastomeric pumps to provide continuous, allowed, high-dose drug delivery for the management of pain and for post-surgery comfort, which creates both patient comfort and cost-saving measures against hospitalization.

By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 30%

By Designation: Directors: 30%, Managers: 20%, and Others: 50%

By Region: North America: 20%, Europe: 10%, Asia Pacific: 40%, South America: 10%, and Middle East & Africa 20%

Notes: Others include sales, marketing, and product managers.

Tier 1: >USD 1 Billion; Tier 2: USD 500 million-1 Billion; and Tier 3: <USD 500 million

Companies Covered: Baxter (US), B. Braun SE (Germany), NIPRO (Japan), AVNS (US), Vygon (France), WOOYOUNG MEDICAL CO., LTD. (South Korea), Shanghai INT Medical Instruments Co., Ltd. (China), Ambu A/S (Denmark), Palex (Spain), and DAIKEN MEDICAL CO., LTD. (Japan) are covered in the report.

The study includes an in-depth competitive analysis of these key players in the elastomeric infusion pumps market, with their company profiles, recent developments, and key market strategies.

Research Coverage

This research report categorizes the elastomeric infusion pumps market based on type (Continuous Rate and Variable Rate), application (Pain Management, Antibiotics, Chemotherapy, and Other Applications), and end-use industry (Hospitals, Ambulatory Surgical Centers (ASCs), Home-care Settings, and Other End-use Industries). The report's scope encompasses detailed information regarding the drivers, restraints, challenges, and opportunities that influence the growth of the elastomeric infusion pumps market. A detailed analysis of key industry players has been conducted to provide insights into their business overview, products offered, and key strategies, including partnerships, collaborations, mergers, acquisitions, and expansions, associated with the elastomeric infusion pumps market. This report covers a competitive analysis of upcoming startups in the elastomeric infusion pumps market ecosystem.

Reasons to Buy the Report

The report will provide market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall elastomeric infusion pumps market and its subsegments. This report will help stakeholders understand the competitive landscape, gain deeper insights into positioning their businesses more effectively, and develop suitable go-to-market strategies. The report will help stakeholders understand the pulse of the market and provide them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following points:

  • Analysis of key drivers (rising prevalence of chronic diseases, growing shift to ambulatory and home-based care, and disposable and portable design), restraints (rising risks of incorrect drug delivery and performance variability, regulatory recalls on elastomeric pump reliability, and stringent regulatory approvals and compliance requirements), opportunities (rising healthcare advancements in emerging economies, and specialization for high-viscosity drugs and biologics), and challenges (intense competition with electronic infusion technologies and maintaining precision and safety in scaled elastomeric pump production).
  • Product Development/Innovation: Detailed insights into upcoming technologies, research & development activities, and product & service launches in the elastomeric infusion pumps market.
  • Market Development: Comprehensive information about profitable markets - the report analyzes the elastomeric infusion pumps market across varied regions.
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the elastomeric infusion pumps market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Baxter (US), B. Braun SE (Germany), NIPRO (Japan), AVNS (US), Vygon (France), WOOYOUNG MEDICAL CO., LTD. (South Korea), Shanghai INT Medical Instruments Co., Ltd. (China), Ambu A/S (Denmark), Palex (Spain), and DAIKEN MEDICAL CO., LTD. (Japan), among others.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
    • 1.3.5 UNITS CONSIDERED
  • 1.4 STAKEHOLDERS

2 EXECUTIVE SUMMARY

  • 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
  • 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS
  • 2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH
  • 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
  • 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

  • 3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN ELASTOMERIC INFUSION PUMPS MARKET
  • 3.2 NORTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE AND COUNTRY
  • 3.3 ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE
  • 3.4 ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION
  • 3.5 ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY
  • 3.6 ELASTOMERIC INFUSION PUMPS MARKET, BY COUNTRY

4 MARKET OVERVIEW

  • 4.1 INTRODUCTION
  • 4.2 MARKET DYNAMICS
    • 4.2.1 DRIVERS
      • 4.2.1.1 Rising prevalence of chronic diseases
      • 4.2.1.2 Growing shift to ambulatory and home-based care
      • 4.2.1.3 Disposable and portable design
    • 4.2.2 RESTRAINTS
      • 4.2.2.1 Rising risks of incorrect drug delivery and performance variability
      • 4.2.2.2 Regulatory recalls on elastomeric pump reliability
      • 4.2.2.3 Stringent regulatory approvals and compliance requirements
    • 4.2.3 OPPORTUNITIES
      • 4.2.3.1 Rising healthcare advancements in emerging economies
      • 4.2.3.2 Specialization for high-viscosity drugs and biologics
    • 4.2.4 CHALLENGES
      • 4.2.4.1 Intense competition with electronic infusion technologies
      • 4.2.4.2 Maintaining precision and safety in scaled elastomeric pump production
  • 4.3 UNMET NEEDS AND WHITE SPACES
    • 4.3.1 UNMET NEEDS IN ELASTOMERIC INFUSION PUMPS MARKET
    • 4.3.2 WHITE SPACE OPPORTUNITIES
  • 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
    • 4.4.1 INTERCONNECTED MARKETS
    • 4.4.2 CROSS-SECTOR OPPORTUNITIES
  • 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
    • 4.5.1 KEY MOVES AND STRATEGIC FOCUS

5 INDUSTRY TRENDS

  • 5.1 PORTER'S FIVE FORCES ANALYSIS
    • 5.1.1 THREAT OF NEW ENTRANTS
    • 5.1.2 THREAT OF SUBSTITUTES
    • 5.1.3 BARGAINING POWER OF SUPPLIERS
    • 5.1.4 BARGAINING POWER OF BUYERS
    • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.2 MACROECONOMIC ANALYSIS
    • 5.2.1 INTRODUCTION
    • 5.2.2 GDP TRENDS AND FORECASTS
  • 5.3 VALUE CHAIN ANALYSIS
  • 5.4 ECOSYSTEM ANALYSIS
  • 5.5 PRICING ANALYSIS
    • 5.5.1 AVERAGE SELLING PRICE OF ELASTOMERIC INFUSION PUMPS, BY TYPE
    • 5.5.2 AVERAGE SELLING PRICE ANALYSIS, BY REGION
  • 5.6 TRADE ANALYSIS
    • 5.6.1 EXPORT SCENARIO (HS CODE 901890)
    • 5.6.2 IMPORT SCENARIO (HS CODE 901890)
  • 5.7 KEY CONFERENCES AND EVENTS, 2025-2026
  • 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
    • 5.8.1 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.9 INVESTMENT AND FUNDING SCENARIO
  • 5.10 CASE STUDY ANALYSIS
    • 5.10.1 MOBILITY ENHANCEMENT IN INFUSION THERAPY USING SUREFUSER+ PUMP
    • 5.10.2 COST-SAVING POTENTIAL OF ELASTOMERIC PUMPS IN POSTOPERATIVE PAIN THERAPY
    • 5.10.3 IMPROVED QUALITY OF LIFE IN CHEMOTHERAPY WITH SUREFUSER+ PUMP
  • 5.11 IMPACT OF 2025 US TARIFF: ELASTOMERIC INFUSION PUMPS MARKET
    • 5.11.1 INTRODUCTION
    • 5.11.2 KEY TARIFF RATES
    • 5.11.3 PRICE IMPACT ANALYSIS
    • 5.11.4 IMPACT ON COUNTRIES/REGIONS
      • 5.11.4.1 US
      • 5.11.4.2 China
      • 5.11.4.3 Europe
      • 5.11.4.4 Brazil
    • 5.11.5 IMPACT ON END-USE INDUSTRIES

6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTIONS

  • 6.1 KEY EMERGING TECHNOLOGIES
    • 6.1.1 PRECISION FLOW CONTROL SYSTEMS AND MULTI-RATE DESIGNS
    • 6.1.2 ADVANCED MATERIALS FOR DRUG STABILITY
    • 6.1.3 ELASTOMERIC MEMBRANE FOR PRESSURE GENERATION
  • 6.2 COMPLEMENTARY TECHNOLOGIES
    • 6.2.1 ANTIMICROBIAL AND BIOCOMPATIBLE MATERIALS
  • 6.3 ADJACENT TECHNOLOGIES
    • 6.3.1 SMART CONNECTIVITY AND IOT INTEGRATION
  • 6.4 TECHNOLOGY/PRODUCT ROADMAP
    • 6.4.1 SHORT-TERM (2025-2027) | FOUNDATION & EARLY COMMERCIALIZATION
    • 6.4.2 MID-TERM (2027-2030) | EXPANSION & INTEGRATION
    • 6.4.3 LONG-TERM (2030-2035+) | MATURITY & AUTONOMOUS SYSTEMS
  • 6.5 PATENT ANALYSIS
    • 6.5.1 INTRODUCTION
    • 6.5.2 METHODOLOGY
    • 6.5.3 ELASTOMERIC INFUSION PUMPS MARKET, PATENT ANALYSIS, 2015-2024
  • 6.6 FUTURE APPLICATIONS
    • 6.6.1 INTEGRATION WITH DIGITAL HEALTH FOR REMOTE MONITORING
    • 6.6.2 EXPANSION INTO VETERINARY AMBULATORY CARE
    • 6.6.3 DELIVERY OF ADVANCED THERAPEUTICS LIKE BIOLOGICS AND GENE THERAPY
    • 6.6.4 BIOLUMINESCENT INDICATOR FILMS
  • 6.7 IMPACT OF AI/GEN AI ON ELASTOMERIC INFUSION PUMPS MARKET
    • 6.7.1 TOP USE CASES AND MARKET POTENTIAL
    • 6.7.2 BEST PRACTICES IN ELASTOMERIC INFUSION PUMP PROCESSING
    • 6.7.3 CASE STUDIES OF AI IMPLEMENTATION IN ELASTOMERIC INFUSION PUMPS MARKET
    • 6.7.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
    • 6.7.5 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN ELASTOMERIC INFUSION PUMPS MARKET
  • 6.8 SUCCESS STORIES AND REAL-WORLD APPLICATIONS
    • 6.8.1 UNIVERSITY OF MICHIGAN DEPLOYS DOSI-FUSER ELASTOMERIC INFUSION SYSTEM FOR HOME CHEMOTHERAPY
    • 6.8.2 PEDIATRIC HOME CHEMOTHERAPY (INTACT@HOME, CANADA)
    • 6.8.3 PALLIATIVE CARE AND END-OF-LIFE SYMPTOM MANAGEMENT (SOUTHERN ONTARIO, CANADA)

7 SUSTAINABILITY AND REGULATORY LANDSCAPE

  • 7.1 REGIONAL REGULATIONS AND COMPLIANCE
    • 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 7.1.2 INDUSTRY STANDARDS
  • 7.2 SUSTAINABILITY INITIATIVES
    • 7.2.1 CARBON IMPACT AND ECO-APPLICATIONS OF ELASTOMERIC INFUSION PUMPS
      • 7.2.1.1 Carbon impact reduction
      • 7.2.1.2 Eco-applications
  • 7.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
  • 7.4 CERTIFICATIONS, LABELING, ECO-STANDARDS

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

  • 8.1 DECISION-MAKING PROCESS
  • 8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
    • 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 8.2.2 BUYING CRITERIA
  • 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
  • 8.4 UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
  • 8.5 MARKET PROFITABILITY
    • 8.5.1 REVENUE POTENTIAL
    • 8.5.2 COST DYNAMICS
    • 8.5.3 MARGIN OPPORTUNITIES, BY APPLICATION

9 ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE

  • 9.1 INTRODUCTION
  • 9.2 CONTINUOUS RATE
    • 9.2.1 DEMAND FOR PRECISE, PORTABLE, AND POWER-FREE DRUG DELIVERY IN OUTPATIENT CARE TO DRIVE MARKET
  • 9.3 VARIABLE RATE
    • 9.3.1 RISING NEED FOR PERSONALIZED AND ADJUSTABLE DRUG DELIVERY IN AMBULATORY CARE TO DRIVE DEMAND

10 ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION

  • 10.1 INTRODUCTION
  • 10.2 CHEMOTHERAPY
    • 10.2.1 RISING CANCER INCIDENCE AND SHIFT TOWARD OUTPATIENT CHEMOTHERAPY DRIVING ADOPTION
  • 10.3 PAIN MANAGEMENT
    • 10.3.1 RISING PREVALENCE OF CHRONIC PAIN AND DEMAND FOR OUTPATIENT ANALGESIC DELIVERY TO SUPPORT MARKET GROWTH
  • 10.4 ANTIBIOTICS
    • 10.4.1 GROWTH OF OUTPATIENT ANTIBIOTIC THERAPY AND HOME-BASED CARE DRIVING ADOPTION
  • 10.5 OTHER APPLICATIONS

11 ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY

  • 11.1 INTRODUCTION
  • 11.2 HOSPITALS
    • 11.2.1 NEED FOR ENHANCING PATIENT CARE AND OPERATIONAL EFFICIENCY TO DRIVE MARKET
  • 11.3 AMBULATORY SURGICAL CENTERS (ASCS)
    • 11.3.1 OFFERS OPTIMIZED OUTPATIENT SURGICAL CARE WITH EFFICIENT DRUG DELIVERY
  • 11.4 HOMECARE SETTINGS
    • 11.4.1 INCREASING DEMAND FOR SAFE AND INDEPENDENT HOME- BASED CARE TO DRIVE MARKET
  • 11.5 OTHER END-USE INDUSTRIES

12 ELASTOMERIC INFUSION PUMPS MARKET, BY REGION

  • 12.1 INTRODUCTION
  • 12.2 NORTH AMERICA
    • 12.2.1 US
      • 12.2.1.1 Rising cancer prevalence driving demand for continuous infusion therapies
    • 12.2.2 CANADA
      • 12.2.2.1 Aging population and increasing cancer cases propelling growth
    • 12.2.3 MEXICO
      • 12.2.3.1 Government health initiatives and rising chronic disease burden to boost demand
  • 12.3 EUROPE
    • 12.3.1 GERMANY
      • 12.3.1.1 Strong healthcare infrastructure and growing preference for home-based care to drive demand
    • 12.3.2 FRANCE
      • 12.3.2.1 Rising oncology cases and preference for outpatient care to boost market growth
    • 12.3.3 UK
      • 12.3.3.1 Strong healthcare infrastructure and rising cancer burden driving demand
    • 12.3.4 ITALY
      • 12.3.4.1 Increasing chronic pain burden driving adoption
    • 12.3.5 SPAIN
      • 12.3.5.1 Rising cancer incidence and aging population fueling demand
    • 12.3.6 REST OF EUROPE
  • 12.4 ASIA PACIFIC
    • 12.4.1 CHINA
      • 12.4.1.1 Growing hospital infrastructure and rising outpatient care fueling adoption
    • 12.4.2 JAPAN
      • 12.4.2.1 Growing aging population to support market growth
    • 12.4.3 INDIA
      • 12.4.3.1 Expanding cancer care infrastructure and home-based treatment driving adoption
    • 12.4.4 SOUTH KOREA
      • 12.4.4.1 Rising healthcare needs and technological integration to accelerate market growth
    • 12.4.5 AUSTRALIA
      • 12.4.5.1 Increased healthcare spending driving market growth
    • 12.4.6 REST OF ASIA PACIFIC
  • 12.5 SOUTH AMERICA
    • 12.5.1 BRAZIL
      • 12.5.1.1 Government healthcare programs and expanding chronic care infrastructure propelling adoption
    • 12.5.2 ARGENTINA
      • 12.5.2.1 Expanding healthcare infrastructure and chronic disease management boosting adoption
    • 12.5.3 REST OF SOUTH AMERICA
  • 12.6 MIDDLE EAST & AFRICA
    • 12.6.1 GCC COUNTRIES
      • 12.6.1.1 Saudi Arabia
        • 12.6.1.1.1 Healthcare transformation and localization initiatives under Vision 2030 to accelerate demand
      • 12.6.1.2 UAE
        • 12.6.1.2.1 Expanding healthcare infrastructure fueling adoption of elastomeric infusion pumps
      • 12.6.1.3 Rest of GCC Countries
    • 12.6.2 SOUTH AFRICA
      • 12.6.2.1 National health insurance implementation and chronic care initiatives to fuel growth
    • 12.6.3 REST OF MIDDLE EAST & AFRICA

13 COMPETITIVE LANDSCAPE

  • 13.1 OVERVIEW
  • 13.2 KEY PLAYERS' STRATEGIES
  • 13.3 MARKET SHARE ANALYSIS
  • 13.4 REVENUE ANALYSIS
  • 13.5 COMPANY VALUATION AND FINANCIAL METRICS
  • 13.6 PRODUCT/BRAND COMPARISON
  • 13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 13.7.1 STARS
    • 13.7.2 EMERGING LEADERS
    • 13.7.3 PERVASIVE PLAYERS
    • 13.7.4 PARTICIPANTS
    • 13.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 13.7.5.1 Company footprint
      • 13.7.5.2 Regional footprint
      • 13.7.5.3 Type footprint
      • 13.7.5.4 Application footprint
      • 13.7.5.5 End-use industry footprint
  • 13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 13.8.1 PROGRESSIVE COMPANIES
    • 13.8.2 RESPONSIVE COMPANIES
    • 13.8.3 DYNAMIC COMPANIES
    • 13.8.4 STARTING BLOCKS
    • 13.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
      • 13.8.5.1 Detailed list of key startups/SMEs
      • 13.8.5.2 Competitive benchmarking of key startups/SMEs
  • 13.9 COMPETITIVE SCENARIO
    • 13.9.1 DEALS
    • 13.9.2 EXPANSIONS

14 COMPANY PROFILES

  • 14.1 KEY PLAYERS
    • 14.1.1 BAXTER
      • 14.1.1.1 Business overview
      • 14.1.1.2 Products/Solutions/Services offered
      • 14.1.1.3 MnM view
        • 14.1.1.3.1 Key strengths
        • 14.1.1.3.2 Strategic choices
        • 14.1.1.3.3 Weaknesses and competitive threats
    • 14.1.2 B. BRAUN SE
      • 14.1.2.1 Business overview
      • 14.1.2.2 Products/Solutions/Services offered
      • 14.1.2.3 Recent developments
        • 14.1.2.3.1 Deals
      • 14.1.2.4 MnM view
        • 14.1.2.4.1 Key strengths
        • 14.1.2.4.2 Strategic choices
        • 14.1.2.4.3 Weaknesses and competitive threats
    • 14.1.3 NIPRO
      • 14.1.3.1 Business overview
      • 14.1.3.2 Products/Solutions/Services offered
      • 14.1.3.3 Recent developments
        • 14.1.3.3.1 Deals
        • 14.1.3.3.2 Expansions
      • 14.1.3.4 MnM view
        • 14.1.3.4.1 Key strengths
        • 14.1.3.4.2 Strategic choices
        • 14.1.3.4.3 Weaknesses and competitive threats
    • 14.1.4 AVNS
      • 14.1.4.1 Business overview
      • 14.1.4.2 Products/Solutions/Services offered
      • 14.1.4.3 MnM view
        • 14.1.4.3.1 Key strengths
        • 14.1.4.3.2 Strategic choices
        • 14.1.4.3.3 Weaknesses and competitive threats
    • 14.1.5 VYGON
      • 14.1.5.1 Business overview
      • 14.1.5.2 Products/Solutions/Services offered
      • 14.1.5.3 Recent developments
        • 14.1.5.3.1 Deals
        • 14.1.5.3.2 Expansions
      • 14.1.5.4 MnM view
        • 14.1.5.4.1 Key strengths
        • 14.1.5.4.2 Strategic choices
        • 14.1.5.4.3 Weaknesses and competitive threats
    • 14.1.6 WOOYOUNG MEDICAL CO., LTD.
      • 14.1.6.1 Business overview
      • 14.1.6.2 Products/Solutions/Services offered
      • 14.1.6.3 MnM view
    • 14.1.7 SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.
      • 14.1.7.1 Business overview
      • 14.1.7.2 Products/Solutions/Services offered
      • 14.1.7.3 Recent developments
        • 14.1.7.3.1 Deals
      • 14.1.7.4 MnM view
    • 14.1.8 AMBU A/S
      • 14.1.8.1 Business overview
      • 14.1.8.2 Products/Solutions/Services offered
      • 14.1.8.3 Recent developments
        • 14.1.8.3.1 Expansions
      • 14.1.8.4 MnM view
    • 14.1.9 PALEX
      • 14.1.9.1 Business overview
      • 14.1.9.2 Products/Solutions/Services offered
      • 14.1.9.3 Recent developments
        • 14.1.9.3.1 Deals
      • 14.1.9.4 MnM view
    • 14.1.10 DAIKEN MEDICAL CO., LTD.
      • 14.1.10.1 Business overview
      • 14.1.10.2 Products/Solutions/Services offered
      • 14.1.10.3 MnM view
  • 14.2 OTHER PLAYERS
    • 14.2.1 PROMECON GMBH
    • 14.2.2 S&S MED
    • 14.2.3 EPIC MEDICAL
    • 14.2.4 MULTIMEDICAL S.R.L.
    • 14.2.5 TECNOLINE S.P.A.
    • 14.2.6 ZHEJIANG FERT MEDICAL DEVICE CO., LTD.
    • 14.2.7 ACE MEDICAL
    • 14.2.8 GAMASTECH SRL
    • 14.2.9 FIRST MEDICAL SOURCE
    • 14.2.10 DELTAMED
    • 14.2.11 VIKYMED ITALIA SRL
    • 14.2.12 CHANGZHOU MEDICAL BIOENGINEERING CO., LTD.
    • 14.2.13 MAIS INDIA
    • 14.2.14 NARANG MEDICAL LIMITED
    • 14.2.15 ZEBRA MEDICAL

15 RESEARCH METHODOLOGY

  • 15.1 RESEARCH DATA
    • 15.1.1 SECONDARY DATA
      • 15.1.1.1 Key data from secondary sources
    • 15.1.2 PRIMARY DATA
      • 15.1.2.1 Key data from primary sources
      • 15.1.2.2 Key industry insights
  • 15.2 MARKET SIZE ESTIMATION
  • 15.3 BASE NUMBER CALCULATION
    • 15.3.1 DEMAND-SIDE APPROACH
    • 15.3.2 SUPPLY-SIDE APPROACH
  • 15.4 MARKET FORECAST APPROACH
    • 15.4.1 SUPPLY SIDE
    • 15.4.2 DEMAND SIDE
  • 15.5 DATA TRIANGULATION
  • 15.6 FACTOR ANALYSIS
  • 15.7 RESEARCH ASSUMPTIONS
  • 15.8 RESEARCH LIMITATIONS AND RISK ASSESSMENT

16 ADJACENT & RELATED MARKETS

  • 16.1 INTRODUCTION
  • 16.2 LIMITATIONS
    • 16.2.1 INFUSION PUMPS MARKET
      • 16.2.1.1 Market definition
      • 16.2.1.2 Infusion pumps market, by product
      • 16.2.1.3 Infusion pumps market, by application
      • 16.2.1.4 Infusion pumps market, by setting
      • 16.2.1.5 Infusion pumps market, by region

17 APPENDIX

  • 17.1 DISCUSSION GUIDE
  • 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 17.3 CUSTOMIZATION OPTIONS
  • 17.4 RELATED REPORTS
  • 17.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 ELASTOMERIC INFUSION PUMPS MARKET: IMPACT OF PORTER'S FIVE FORCES
  • TABLE 2 GLOBAL GDP GROWTH PROJECTION, BY REGION, 2021-2028 (USD TRILLION)
  • TABLE 3 ELASTOMERIC INFUSION PUMPS MARKET: ROLES OF COMPANIES IN ECOSYSTEM
  • TABLE 4 AVERAGE SELLING PRICE OF KEY PLAYERS, BY TYPE, 2024 (USD/UNIT)
  • TABLE 5 AVERAGE SELLING PRICE TREND OF ELASTOMERIC INFUSION PUMPS, BY REGION, 2023-2030 (USD/UNIT)
  • TABLE 6 EXPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024 (USD MILLION)
  • TABLE 7 IMPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024 (USD MILLION)
  • TABLE 8 ELASTOMERIC INFUSION PUMPS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS, 2025-2026
  • TABLE 9 ELASTOMERIC INFUSION PUMPS MARKET: LIST OF KEY PATENTS, 2022-2024
  • TABLE 10 TOP USE CASES AND MARKET POTENTIAL
  • TABLE 11 BEST PRACTICES: COMPANIES IMPLEMENTING USE CASES
  • TABLE 12 ELASTOMERIC INFUSION PUMPS MARKET: CASE STUDIES RELATED TO GEN AI IMPLEMENTATION
  • TABLE 13 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS
  • TABLE 14 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS
  • TABLE 15 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS
  • TABLE 16 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS
  • TABLE 17 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, INDUSTRY ASSOCIATIONS, AND OTHER ORGANIZATIONS
  • TABLE 18 GLOBAL INDUSTRY STANDARDS IN ELASTOMERIC INFUSION PUMPS MARKET
  • TABLE 19 CERTIFICATIONS, LABELING, ECO-STANDARDS IN ELASTOMERIC INFUSION PUMPS MARKET
  • TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END-USE INDUSTRY (%)
  • TABLE 21 KEY BUYING CRITERIA, BY END-USE INDUSTRY
  • TABLE 22 UNMET NEEDS IN ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY
  • TABLE 23 ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 24 ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 25 ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 26 ELASTOMERIC INFUSION PUMPS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 27 NORTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 28 NORTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 29 NORTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 30 NORTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 31 US: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 32 US: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 33 US: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 34 CANADA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 35 CANADA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 36 CANADA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 37 MEXICO: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 38 MEXICO: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 39 MEXICO: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 40 EUROPE: ELASTOMERIC INFUSION PUMPS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 41 EUROPE: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 42 EUROPE: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 43 EUROPE: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 44 GERMANY: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 45 GERMANY: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 46 GERMANY: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 47 FRANCE: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 48 FRANCE: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 49 FRANCE: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 50 UK: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 51 UK: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 52 UK: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 53 ITALY: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 54 ITALY: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 55 ITALY: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 56 SPAIN: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 57 SPAIN: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 58 SPAIN: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 59 REST OF EUROPE: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 60 REST OF EUROPE: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 61 REST OF EUROPE: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 62 ASIA PACIFIC: ELASTOMERIC INFUSION PUMPS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 63 ASIA PACIFIC: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 64 ASIA PACIFIC: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 65 ASIA PACIFIC: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 66 CHINA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 67 CHINA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 68 CHINA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 69 JAPAN: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 70 JAPAN: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 71 JAPAN: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 72 INDIA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 73 INDIA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 74 INDIA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 75 SOUTH KOREA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 76 SOUTH KOREA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 77 SOUTH KOREA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 78 AUSTRALIA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 79 AUSTRALIA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 80 AUSTRALIA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 81 REST OF ASIA PACIFIC: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 82 REST OF ASIA PACIFIC: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 83 REST OF ASIA PACIFIC: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 84 SOUTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 85 SOUTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 86 SOUTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 87 SOUTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 88 BRAZIL: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 89 BRAZIL: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 90 BRAZIL: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 91 ARGENTINA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 92 ARGENTINA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 93 ARGENTINA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 94 REST OF SOUTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 95 REST OF SOUTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 96 REST OF SOUTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 97 MIDDLE EAST & AFRICA: ELASTOMERIC INFUSION PUMPS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 98 MIDDLE EAST & AFRICA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 99 MIDDLE EAST & AFRICA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 100 MIDDLE EAST & AFRICA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 101 GCC COUNTRIES: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 102 GCC COUNTRIES: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 103 GCC COUNTRIES: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 104 SAUDI ARABIA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 105 SAUDI ARABIA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 106 SAUDI ARABIA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 107 UAE: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 108 UAE: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 109 UAE: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 110 REST OF GCC COUNTRIES: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 111 REST OF GCC COUNTRIES: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 112 REST OF GCC COUNTRIES: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 113 SOUTH AFRICA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 114 SOUTH AFRICA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 115 SOUTH AFRICA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 116 REST OF MIDDLE EAST & AFRICA: ELASTOMERIC INFUSION PUMPS MARKET, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 117 REST OF MIDDLE EAST & AFRICA: ELASTOMERIC INFUSION PUMPS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 118 REST OF MIDDLE EAST & AFRICA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023-2030 (USD MILLION)
  • TABLE 119 ELASTOMERIC INFUSION PUMPS MARKET: OVERVIEW OF MAJOR STRATEGIES ADOPTED BY KEY PLAYERS, JANUARY 2020-OCTOBER 2025
  • TABLE 120 ELASTOMERIC INFUSION PUMPS MARKET: DEGREE OF COMPETITION, 2024
  • TABLE 121 ELASTOMERIC INFUSION PUMPS MARKET: REGIONAL FOOTPRINT, 2024
  • TABLE 122 ELASTOMERIC INFUSION PUMPS MARKET: TYPE FOOTPRINT, 2024
  • TABLE 123 ELASTOMERIC INFUSION PUMPS MARKET: APPLICATION FOOTPRINT, 2024
  • TABLE 124 ELASTOMERIC INFUSION PUMPS MARKET: END-USE INDUSTRY FOOTPRINT, 2024
  • TABLE 125 ELASTOMERIC INFUSION PUMPS MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2024
  • TABLE 126 ELASTOMERIC INFUSION PUMPS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, 2024
  • TABLE 127 ELASTOMERIC INFUSION PUMPS MARKET: DEALS, JANUARY 2020-OCTOBER 2025
  • TABLE 128 ELASTOMERIC INFUSION PUMPS MARKET: EXPANSIONS, JANUARY 2020-OCTOBER 2025
  • TABLE 129 BAXTER: COMPANY OVERVIEW
  • TABLE 130 BAXTER: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 131 B. BRAUN SE: COMPANY OVERVIEW
  • TABLE 132 B. BRAUN SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 133 B. BRAUN SE: DEALS
  • TABLE 134 NIPRO: COMPANY OVERVIEW
  • TABLE 135 NIPRO: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 136 NIPRO: DEALS
  • TABLE 137 NIPRO: EXPANSIONS
  • TABLE 138 AVNS: COMPANY OVERVIEW
  • TABLE 139 AVNS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 140 VYGON: COMPANY OVERVIEW
  • TABLE 141 VYGON: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 142 VYGON: DEALS
  • TABLE 143 VYGON: EXPANSIONS
  • TABLE 144 WOOYOUNG MEDICAL CO., LTD.: COMPANY OVERVIEW
  • TABLE 145 WOOYOUNG MEDICAL CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 146 SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.: COMPANY OVERVIEW
  • TABLE 147 SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.: PRODUCTS/ SOLUTIONS/ SERVICES OFFERED
  • TABLE 148 SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.: DEALS
  • TABLE 149 AMBU A/S: COMPANY OVERVIEW
  • TABLE 150 AMBU A/S: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 151 AMBU A/S: EXPANSIONS
  • TABLE 152 PALEX: COMPANY OVERVIEW
  • TABLE 153 PALEX: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 154 PALEX: DEALS
  • TABLE 155 DAIKEN MEDICAL CO., LTD.: COMPANY OVERVIEW
  • TABLE 156 DAIKEN MEDICAL CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 157 PROMECON GMBH: COMPANY OVERVIEW
  • TABLE 158 S&S MED: COMPANY OVERVIEW
  • TABLE 159 EPIC MEDICAL: COMPANY OVERVIEW
  • TABLE 160 MULTIMEDICAL S.R.L.: COMPANY OVERVIEW
  • TABLE 161 TECNOLINE S.P.A.: COMPANY OVERVIEW
  • TABLE 162 ZHEJIANG FERT MEDICAL DEVICE CO., LTD.: COMPANY OVERVIEW
  • TABLE 163 ACE MEDICAL: COMPANY OVERVIEW
  • TABLE 164 GAMASTECH SRL: COMPANY OVERVIEW
  • TABLE 165 FIRST MEDICAL SOURCE: COMPANY OVERVIEW
  • TABLE 166 DELTAMED: COMPANY OVERVIEW
  • TABLE 167 VIKYMED ITALIA SRL: COMPANY OVERVIEW
  • TABLE 168 CHANGZHOU MEDICAL BIOENGINEERING CO., LTD.: COMPANY OVERVIEW
  • TABLE 169 MAIS INDIA: COMPANY OVERVIEW
  • TABLE 170 NARANG MEDICAL LIMITED: COMPANY OVERVIEW
  • TABLE 171 ZEBRA MEDICAL: COMPANY OVERVIEW
  • TABLE 172 INFUSION PUMPS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
  • TABLE 173 INFUSION PUMPS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
  • TABLE 174 INFUSION PUMPS MARKET, BY SETTING, 2020-2027 (USD MILLION)
  • TABLE 175 INFUSION PUMPS MARKET, BY REGION, 2020-2027 (USD MILLION)

List of Figures

  • FIGURE 1 ELASTOMERIC INFUSION PUMPS MARKET SEGMENTATION AND REGIONAL SCOPE
  • FIGURE 2 KEY INSIGHTS AND MARKET HIGHLIGHTS
  • FIGURE 3 GLOBAL ELASTOMERIC INFUSION PUMPS MARKET, 2023-2030
  • FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN ELASTOMERIC INFUSION PUMPS MARKET (2020-2025)
  • FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF ELASTOMERIC INFUSION PUMPS MARKET DURING FORECAST PERIOD
  • FIGURE 6 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN ELASTOMERIC INFUSION PUMPS MARKET, 2024
  • FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 8 HIGH DEMAND IN HOSPITALS AND HOMECARE SETTINGS TO CREATE LUCRATIVE OPPORTUNITIES FOR MARKET PLAYERS
  • FIGURE 9 US DOMINATED ELASTOMERIC INFUSION PUMPS MARKET IN NORTH AMERICA
  • FIGURE 10 CONTINUOUS RATE SEGMENT DOMINATED ELASTOMERIC INFUSION PUMPS MARKET IN 2024
  • FIGURE 11 PAIN MANAGEMENT SEGMENT ACCOUNTED FOR LARGEST SHARE OF ELASTOMERIC INFUSION PUMPS MARKET IN 2024
  • FIGURE 12 HOSPITALS SEGMENT ACCOUNTED FOR LARGEST SHARE OF ELASTOMERIC INFUSION PUMPS MARKET IN 2024
  • FIGURE 13 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 14 ELASTOMERIC INFUSION PUMPS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 15 US CANCER SURVIVORS (MALE & FEMALE) BY YEARS SINCE DIAGNOSIS, AS OF JANUARY 2025
  • FIGURE 16 ELASTOMERIC INFUSION PUMPS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 17 ELASTOMERIC INFUSION PUMPS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 18 ELASTOMERIC INFUSION PUMPS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 19 AVERAGE SELLING PRICE OF KEY PLAYERS, BY TYPE, 2024
  • FIGURE 20 AVERAGE SELLING PRICE TREND OF ELASTOMERIC INFUSION PUMPS, BY REGION, 2023-2030
  • FIGURE 21 EXPORT SCENARIO FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024
  • FIGURE 22 IMPORT SCENARIO FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024
  • FIGURE 23 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • FIGURE 24 INVESTMENT AND FUNDING SCENARIO, 2018-2024
  • FIGURE 25 LIST OF MAJOR PATENTS FOR ELASTOMERIC INFUSION PUMPS, 2015-2024
  • FIGURE 26 MAJOR PATENTS APPLIED AND GRANTED RELATED TO ELASTOMERIC INFUSION PUMPS, BY COUNTRY/REGION, 2015-2024
  • FIGURE 27 ELASTOMERIC INFUSION PUMPS MARKET DECISION-MAKING FACTORS
  • FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END-USE INDUSTRY
  • FIGURE 29 KEY BUYING CRITERIA, BY END-USE INDUSTRY
  • FIGURE 30 ADOPTION BARRIERS & INTERNAL CHALLENGES
  • FIGURE 31 CONTINUOUS RATE SEGMENT TO DOMINATE ELASTOMERIC INFUSION PUMPS MARKET DURING FORECAST PERIOD
  • FIGURE 32 PAIN MANAGEMENT TO ACCOUNT FOR LARGEST SHARE OF ELASTOMERIC INFUSION PUMPS MARKET IN 2025
  • FIGURE 33 HOSPITALS TO BE LARGEST END-USE INDUSTRY OF ELASTOMERIC INFUSION PUMPS IN 2025
  • FIGURE 34 CHINA TO BE FASTEST-GROWING MARKET DURING FORECAST PERIOD
  • FIGURE 35 NORTH AMERICA TO ACCOUNT FOR LARGEST SHARE OF ELASTOMERIC INFUSION PUMPS MARKET IN 2025
  • FIGURE 36 NORTH AMERICA: ELASTOMERIC INFUSION PUMPS MARKET SNAPSHOT
  • FIGURE 37 EUROPE: ELASTOMERIC INFUSION PUMPS MARKET SNAPSHOT
  • FIGURE 38 ELASTOMERIC INFUSION PUMPS: MARKET SHARE ANALYSIS, 2024
  • FIGURE 39 ELASTOMERIC INFUSION PUMPS MARKET: REVENUE ANALYSIS OF KEY COMPANIES, 2020-2024
  • FIGURE 40 ELASTOMERIC INFUSION PUMPS MARKET: COMPANY VALUATION, 2024
  • FIGURE 41 ELASTOMERIC INFUSION PUMPS MARKET: FINANCIAL MATRIX: EV/ EBITDA RATIO, 2024
  • FIGURE 42 ELASTOMERIC INFUSION PUMPS MARKET: YEAR-TO-DATE PRICE AND FIVE-YEAR STOCK BETA, 2024
  • FIGURE 43 ELASTOMERIC INFUSION PUMPS MARKET: PRODUCT/BRAND COMPARISON
  • FIGURE 44 ELASTOMERIC INFUSION PUMPS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 45 ELASTOMERIC INFUSION PUMPS MARKET: COMPANY FOOTPRINT, 2024
  • FIGURE 46 ELASTOMERIC INFUSION PUMPS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 47 BAXTER: COMPANY SNAPSHOT
  • FIGURE 48 B. BRAUN SE: COMPANY SNAPSHOT
  • FIGURE 49 NIPRO: COMPANY SNAPSHOT
  • FIGURE 50 AVNS: COMPANY SNAPSHOT
  • FIGURE 51 SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.: COMPANY SNAPSHOT
  • FIGURE 52 AMBU A/S: COMPANY SNAPSHOT
  • FIGURE 53 DAIKEN MEDICAL CO., LTD.: COMPANY SNAPSHOT
  • FIGURE 54 ELASTOMERIC INFUSION PUMPS MARKET: RESEARCH DESIGN
  • FIGURE 55 BREAKDOWN OF INTERVIEWS WITH EXPERTS
  • FIGURE 56 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 57 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 58 ELASTOMERIC INFUSION PUMPS MARKET: APPROACH 1
  • FIGURE 59 ELASTOMERIC INFUSION PUMPS MARKET: APPROACH 2
  • FIGURE 60 ELASTOMERIC INFUSION PUMPS MARKET: DATA TRIANGULATION